Organization
Hospital Infantil Universitario Niño Jesus
1 abstract
Abstract
Safety and PK (pharmacokinetic) profile of niraparib (nir) + dostarlimab (dost) in pediatric patients (pts) with recurrent or refractory (RR) solid tumors: SCOOP study.Org: Institut Curie, Saint Cloud, France, University of Paris-Saclay, Hôpital Pour Enfants De La Timone, Hospital Universitario 12 de Octubre, Hospital U i P La Fe,